Category: Side Effect: Pancreatitis (inflammation of pancreas)
-
Ozempic Tablets and Rybelsus Pancreatitis Side Effects Warnings 2026 Update
Acute Pancreatitis, Including Fatal Hemorrhagic And Necrotizing Pancreatitis – Death Cases (Posted by Tom Lamb at Drug Injury Watch) In October 2025, Rybelsus pancreatitis side effects warnings were added to the Rybelsus “drug label”, and in late…
-
Actemra Side Effects: Pulmonary Hypertension, Interstitial Lung Disease, Pulmonary Alveolar Proteinosis
FDA Watch List Includes Actemra: Evaluating Regulatory Action Based On Possible Signs Of Serious Risk, New Safety Information (Posted by Tom Lamb at DrugInjuryWatch.com) In July 2018 the FDA issued this document,…
-
Viberzi – Pancreatitis Side Effects Can Develop At Any Time While Taking This IBS Drug, According To FDA Safety Warning
Severe Cases Of Pancreatitis And Sphincter Of Oddi Spasm Reported Even After Just The First Dose Of Viberzi, With Some Resulting In Patient Deaths (Posted by Tom Lamb at DrugInjuryWatch.com) In March…
-
Despite The High Number Of Actemra – Pancreatitis Cases Reported To FDA, No Warning Added To Drug Label
June 2017 Investigative Article Published By STAT Calls Into Question FDA Oversight After Drugs Are Approved By Agency (Posted by Tom Lamb at DrugInjuryWatch.com) Actemra (tocilizumab) is approved by the FDA for…
-
Iclusig: Leukemia Drug With Many Different Serious Side Effects Had More Warnings Added In November 2016
Black-Box Warning Now Includes Venous Thromboembolism As Well As Various Types Of Arterial Occlusions, And There Are More New Safety Issues (Posted by Tom Lamb at DrugInjuryWatch.com) Iclusig (ponatinib) is a kinase…
-
Emerging Drug Safety Issue: Possible Increased Risk Of Pancreatic Cancer With Byetta, Januvia, And Victoza — Little Is Known About Long-Term Effects
As “Pancreatitis Is On The Pathway Toward Pancreatic Cancer”, Medical Studies Needed To Determine If GLP-1 Diabetes Medications Linked To Cancers Or Malignancies Involving Pancreas (Posted by Tom Lamb at DrugInjuryWatch.com)______________________________________________________________________________ UPDATE: “Cancer of The Pancreas:…
-
The Drug-Induced Pancreatitis Safety Problem That Hangs Around Victoza Gets Another Look
The Relatively New Diabetes Medication Victoza From Novo Nordisk Was Only Approved By FDA In 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) In November 2012 The Annals of Pharmacotherapy published online before print this new…
-
The Victoza – Pancreatitis Issue: Some Related Developments From April 2011 To April 2012
A Drug Safety Controversy Continues: Whether It Is The Diabetes Drug Or The Diabetes Which Causes Pancreas Disease (Posted by Tom Lamb at DrugInjuryWatch.com) As regards the possible association between Victoza and pancreatitis as…
-
Byetta And Januvia: More Debate About The Possible Increased Risk Of Pancreatitis, Pancreatic Cancer, And Thyroid Cancer
Level Of Concern About These Incretin Therapies For Diabetes Was Raised By Gastroenterology Medical Journal Article (Posted by Tom Lamb at DrugInjuryWatch.com) In September 2011, at the 47th European Association for the Study of…
-
Acute Pancreatitis Case Associated With Victoza Use, Similar To Byetta And Januvia Case Reports
Drug Safety Issue Controversy Continues: True Serious Side Effect, Or Attributable To Type 2 Diabetes Condition (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Victoza (liraglutide [rDNA origin]) Injection: REMS – Risk of Thyroid…